EMA Withdrawn: Insulin Human Winthrop (Insulin human) — sanofi-aventis Deutschland GmbH

View source ↗

Summary

EMA withdrew Insulin Human Winthrop (insulin human) from the market in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulin Human Winthrop (insulin human)

Snippet

Status: Withdrawn. Therapeutic area: Diabetes Mellitus. MAH: sanofi-aventis Deutschland GmbH. Decision date: 28/04/2016